Literature DB >> 7691085

Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture.

M C Re1, G Zauli, D Gibellini, G Furlini, E Ramazzotti, P Monari, S Ranieri, S Capitani, M La Placa.   

Abstract

OBJECTIVE: To determine the mechanism underlying the poor growth in vitro of haematopoietic progenitor cells isolated from HIV-1-infected patients.
METHOD: Apoptotic death in liquid culture of bone-marrow CD34+ cells obtained from 11 HIV-1-seropositive patients and 18 HIV-1-seronegative donors was quantitatively monitored by a flow cytometry procedure.
RESULTS: No significant differences in the percentage of apoptotic cells were noted between the two groups immediately after purification. When CD34+ cells were placed in liquid cultures supplemented with 2 ng/ml interleukin-3, the number of apoptotic cells progressively and significantly (P < 0.05) increased in all HIV-1-seropositive patients, while it remained constant in HIV-1-seronegative individuals. Although all HIV-1-seropositive patients showed signs of active viral replication in the bone-marrow micro-environment, progenitor CD34+ cells did not show the presence of active and/or latent HIV-1 infection.
CONCLUSION: Our data demonstrate that CD34+ cells isolated from AIDS patients with active HIV-1 replication in bone-marrow accessory cells are committed to apoptotic death without being directly affected by productive infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691085     DOI: 10.1097/00002030-199308000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  17 in total

1.  The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.

Authors:  Francesco Carinci; Lorenzo Monasta; Corrado Rubini; Daniela Stramazzotti; Annalisa Palmieri; Elisabetta Melloni; Alex Knowles; Luca Ronfani; Giorgio Zauli; Paola Secchiero
Journal:  Invest New Drugs       Date:  2010-11-18       Impact factor: 3.850

Review 2.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

3.  Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL.

Authors:  Arianna Gonelli; Oriano Radillo; Sara Drioli; Erika Rimondi; Paola Secchiero; Gian Maria Bonora
Journal:  Invest New Drugs       Date:  2010-12-02       Impact factor: 3.850

4.  Effects of HIV-1 gp120 and protease inhibitors on apoptotic susceptibility of CD34+ hematopoietic progenitor cells.

Authors:  Owen J MacEneaney; Elizabeth Connick; Christopher A DeSouza
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

Review 5.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

6.  Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells.

Authors:  Erika Rimondi; Maria Grazia di Iasio; Arianna Gonelli; Claudio Celeghini; Paola Secchiero; Giorgio Zauli
Journal:  Invest New Drugs       Date:  2011-05-04       Impact factor: 3.850

Review 7.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

8.  Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1.

Authors:  T Lazzarotto; G Furlini; M C Re; E Ramazzotti; B Campisi; M P Landini
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 9.  Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells.

Authors:  M C Re; G Furlini; G Zauli; M La Placa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection.

Authors:  Timo Z Nazari-Shafti; Eva Freisinger; Upal Roy; Christine T Bulot; Christiane Senst; Charles L Dupin; Abigail E Chaffin; Sudesh K Srivastava; Debasis Mondal; Eckhard U Alt; Reza Izadpanah
Journal:  Retrovirology       Date:  2011-01-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.